Takeda stock: Results are due October 29, 2026 for Takeda stock
Published on 10/19/2026 at 16:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSScheduled results and valuation
- Takeda announced on October 15, 2026 that its second-quarter results will be presented on October 29, 2026.
- Takeda's market capitalization was USD 62.9 billion as of October 19, 2026.
- Takeda stock costs EUR 17.40 at Lang & Schwarz on October 19, 2026 at 4:03 p.m. CEST.
- Takeda's price-to-earnings ratio was 55.66 as of October 19, 2026.
Takeda will present its second-quarter results for fiscal year 2026 on October 29, 2026, after the company announced the date on October 15. The scheduled report gives investors a defined event to follow as Takeda stock stands at EUR 17.40 at Lang & Schwarz on October 19, 2026 at 4:03 p.m. CEST.
Results date sets the next checkpoint
Takeda said on October 15, 2026 that the earnings call will cover the second quarter of fiscal year 2026. The company scheduled the presentation and question-and-answer session for 7:00 p.m. to 8:15 p.m. Japan time, which is 6:00 a.m. to 7:15 a.m. Eastern time.
The October 29 date matters because it is the next clearly scheduled reporting event for the company. Takeda's investor page also identifies the release as the fiscal year 2026 second-quarter earnings announcement, with presentation materials due on the same date.
Market value and valuation
Takeda's market capitalization was USD 62.9 billion as of October 19, 2026. The price-to-earnings ratio was 55.66 on the same date, while the trailing dividend yield was 0.03 percent. These figures describe the valuation at the NYSE listing and are separate from the euro quotation in Germany.
On the NYSE, Takeda was trading at USD 19.77 on October 19, 2026 at 10:10 a.m. Eastern time, up 0.53 percent from USD 19.67. Takeda's 52-week range was USD 12.99 to USD 19.89, putting the US-listed price USD 0.12 below the upper boundary.
Comparison with peers
Takeda (NYSE, USD): plus 0.53 percent, P/E 55.66, market capitalization USD 62.9 billion
Novartis (NYSE, USD): minus 0.03 percent, P/E 22.96, market capitalization USD 286.2 billion
AstraZeneca (NYSE, USD): plus 0.20 percent, P/E 24.79, market capitalization USD 257.0 billion
What comes next for the stock
The next dated corporate event is the fiscal year 2026 second-quarter earnings announcement on October 29, 2026, followed by the scheduled webcast. The October 15 release names Takeda's TSE and NYSE listings, confirming the US exchange context used for the comparison.
Trading level in Germany
Takeda's euro quotation was EUR 17.40 at Lang & Schwarz on October 19, 2026 at 4:03 p.m. CEST. The bid was EUR 17.20 and the ask was EUR 17.60, leaving a EUR 0.40 spread in the displayed quote.
The further course of trading is shown by the continuously updated real-time quote of Takeda stock.
Takeda stock facts
- Company: Takeda Pharmaceutical Company Limited
- ISIN: US8740602052
- Ticker: TAK
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 19, 2026, 4:03 p.m. CEST): EUR 17.40
- NYSE daily change: plus 0.53 percent
- Market capitalization: USD 62.9 billion (as of October 19, 2026)
- 52-week range: USD 12.99-19.89 (as of October 19, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
Market context: Market report S&P 500.
